Cerebral abscess due to

Ampicillin Gentamicin Hemiparesis Immunodeficiency

Journal

IDCases
ISSN: 2214-2509
Titre abrégé: IDCases
Pays: Netherlands
ID NLM: 101634540

Informations de publication

Date de publication:
2023
Historique:
received: 07 04 2023
revised: 27 07 2023
accepted: 27 07 2023
medline: 14 8 2023
pubmed: 14 8 2023
entrez: 14 8 2023
Statut: epublish

Résumé

Invasive listeriosis most often presents as bacteremia or neurolisteriosis. Cerebral infection mostly manifests as meningitis or meningoencephalitis, but cerebral abscesses are a rare manifestation. We present the rare case of a 51-year old patient with progressive right sided hemiparesis caused by a cerebral abscess due to For the treatment of bacterial brain abscesses, 4-6 weeks of intravenous antimicrobial treatment after surgical drainage are recommended. However, first line therapy of invasive cerebral listeriosis is not well established. We decided to use a combined treatment using ampicillin and gentamicin, followed by prolonged oral treatment due to ongoing tissue inflammation. No evidence-based treatment recommendations are available for brain abscess caused by

Identifiants

pubmed: 37577046
doi: 10.1016/j.idcr.2023.e01864
pii: S2214-2509(23)00188-9
pmc: PMC10415914
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e01864

Informations de copyright

© 2023 The Authors.

Déclaration de conflit d'intérêts

The authors have no relevant financial or non-financial interests to disclose.

Références

Ann Pharmacother. 2000 May;34(5):656-61
pubmed: 10852095
EFSA J. 2021 Dec 13;19(12):e06971
pubmed: 36329690
BMJ Case Rep. 2014 Jul 21;2014:
pubmed: 25053670
Int J Infect Dis. 2010 Oct;14 Suppl 4:S79-92
pubmed: 20846891
Postgrad Med J. 1984 Apr;60(702):267-9
pubmed: 6728749
Virulence. 2021 Dec;12(1):2509-2545
pubmed: 34612177
Infect Immun. 2015 Jun;83(6):2409-19
pubmed: 25824833
Clin Infect Dis. 2000 Sep;31(3):770-5
pubmed: 11017828
Case Rep Infect Dis. 2018 Jul 24;2018:6549496
pubmed: 30140475
Clin Infect Dis. 2009 Dec 15;49(12):1838-47
pubmed: 19929384
Lancet. 1993 Feb 6;341(8841):335-9
pubmed: 8094114
EFSA J. 2018 Jan 24;16(1):e05134
pubmed: 32760461
Clin Infect Dis. 2020 Aug 14;71(4):1040-1046
pubmed: 31641757
Clin Pharmacol Ther. 1989 Jan;45(1):22-7
pubmed: 2910634
J Neurol. 1993;240(4):235-42
pubmed: 8496712
FEMS Immunol Med Microbiol. 2003 Apr 1;35(3):173-5
pubmed: 12648833

Auteurs

Markus Steinbrecher (M)

Internal Medicine III - Gastroenterology and Infectious Diseases, University Hospital of Augsburg, Stenglinstr. 2, 86156 Augsburg, Germany.

Christina Wolfert (C)

Department of Neurosurgery, University Hospital of Augsburg, Stenglinstr. 2, 86156 Augsburg, Germany.

Christoph Maurer (C)

Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital of Augsburg, Stenglinstr. 2, 86156 Augsburg, Germany.

Helmut Messmann (H)

Internal Medicine III - Gastroenterology and Infectious Diseases, University Hospital of Augsburg, Stenglinstr. 2, 86156 Augsburg, Germany.

Ehab Shiban (E)

Department of Neurosurgery, University Hospital of Augsburg, Stenglinstr. 2, 86156 Augsburg, Germany.

Björn Sommer (B)

Department of Neurosurgery, University Hospital of Augsburg, Stenglinstr. 2, 86156 Augsburg, Germany.

Andre Fuchs (A)

Internal Medicine III - Gastroenterology and Infectious Diseases, University Hospital of Augsburg, Stenglinstr. 2, 86156 Augsburg, Germany.

Classifications MeSH